TMEM127 suppresses tumor development by promoting RET ubiquitination, positioning, and degradation

The TMEM127 gene encodes a transmembrane protein of poorly known function that is mutated in pheochromocytomas, neural crest-derived tumors of adrenomedullary cells. Here, we report that, at single-nucleus resolution, TMEM127-mutant tumors share precursor cells and transcription regulatory elements...

Full description

Saved in:
Bibliographic Details
Published inCell reports (Cambridge) Vol. 42; no. 9; p. 113070
Main Authors Guo, Qianjin, Cheng, Zi-Ming, Gonzalez-Cantú, Hector, Rotondi, Matthew, Huelgas-Morales, Gabriela, Ethiraj, Purushoth, Qiu, Zhijun, Lefkowitz, Jonathan, Song, Wan, Landry, Bethany N., Lopez, Hector, Estrada-Zuniga, Cynthia M., Goyal, Shivi, Khan, Mohammad Aasif, Walker, Timothy J., Wang, Exing, Li, Faqian, Ding, Yanli, Mulligan, Lois M., Aguiar, Ricardo C.T., Dahia, Patricia L.M.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 26.09.2023
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The TMEM127 gene encodes a transmembrane protein of poorly known function that is mutated in pheochromocytomas, neural crest-derived tumors of adrenomedullary cells. Here, we report that, at single-nucleus resolution, TMEM127-mutant tumors share precursor cells and transcription regulatory elements with pheochromocytomas carrying mutations of the tyrosine kinase receptor RET. Additionally, TMEM127-mutant pheochromocytomas, human cells, and mouse knockout models of TMEM127 accumulate RET and increase its signaling. TMEM127 contributes to RET cellular positioning, trafficking, and lysosome-mediated degradation. Mechanistically, TMEM127 binds to RET and recruits the NEDD4 E3 ubiquitin ligase for RET ubiquitination and degradation via TMEM127 C-terminal PxxY motifs. Lastly, increased cell proliferation and tumor burden after TMEM127 loss can be reversed by selective RET inhibitors in vitro and in vivo. Our results define TMEM127 as a component of the ubiquitin system and identify aberrant RET stabilization as a likely mechanism through which TMEM127 loss-of-function mutations cause pheochromocytoma. [Display omitted] •TMEM127 loss of function leads to increased RET surface expression and activation•TMEM127 recruits the NEDD4 E3 ligase to RET and promotes its ubiquitination•NEDD4-mediated RET ubiquitination involves the TMEM127 C terminus•Oncogenesis due to TMEM127 deficiency is responsive to RET inhibition Guo et al. report that TMEM127 deficiency leads to pheochromocytoma by reducing NEDD4-mediated RET ubiquitination, positioning, and degradation and that the resulting cell proliferation is responsive to RET selective inhibition.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
AUTHOR CONTRIBUTIONS
Conceptualization, Q.G., P.L.M.D., and R.C.T.A.; snRNA-seq and bioinformatics, Q.G.; molecular studies, Q.G., Z.-M.C., M.R., H.G.C, M.A.K., W.S., B.N.L., C.E.Z., H.K., M.A.K., S.G., P.E., and Z.Q.; mouse models, Q.G., P.E., and Z.Q.; confocal microscopy, Q.G., G.H.-M., W.S., and E.W.; pathology, Y.D. and F.L.; resources, Q.G., H.C.G., H.L., S.G., R.C.T.A., T.J.W., L.M.M., and P.L.M.D.; writing, Q.G., R.C.T.A., and P.L.M.; supervision, P.L.M.D.; funding acquisition, R.C.T.A. and P.L.M.D.
ISSN:2211-1247
2211-1247
DOI:10.1016/j.celrep.2023.113070